Medical Device, Drug & Disease Registries > Portfolio Management
Ascon Health can assist pharmaceutical and biotechnology companies in the complex process of managing and optimizing the strategic assets in a pharmaceutical development product portfolio. Our unique strengths in information technology with the sciences of pharmacology, drug and disease modeling, and clinical development, all directed at improving decision-making processes critical to accelerating drug development in today’s competitive environment.
We collaborate with our clients around a rational process, assisted by advanced technology, to support critical decision-making. This approach leverages both internal resources and external resources and provides a concrete quantitative basis for decisions that had traditionally been based largely on qualitative assessments.
These improved decision processes enable optimization of strategies for risk-return management, resulting in more drug approvals, with better labels, in less time. We can help integrate functional areas of the drug development organization more smoothly, using sophisticated methods of evaluating alternative strategies more efficiently, and systematically adopting a strategic, quantitative, and innovation-focused perspective at all levels of decision-making.